Healthcare -
Biotechnology - NASDAQ - US
$ 1.83
-1.08 %
$ 399 M
Market Cap
-8.32
P/E
AKBA - TOTAL LIABILITIES
Total Liabilities AKBA - Akebia Therapeutics, Inc.
272 M
LAST VALUE
-22.13%
2 YEAR CAGR
-5.46%
5 YEAR CAGR
52.86%
10 YEAR CAGR